| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NONE | Common Stock | Disposed to Issuer | -201K | -100% | 0 | Oct 1, 2021 | By Streiff Family Trust, UA DTD 3/26/13 | F1, F2 | ||
| transaction | NONE | Common Stock | Disposed to Issuer | -22.2K | -100% | 0 | Oct 1, 2021 | By Griffin-American Healthcare REIT III Advisor, LLC | F1, F3 |
Mathieu B. Streiff is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | Reflects the disposition of shares of the Issuer's common stock in connection with the merger (the "Merger") of the Issuer with and into Continental Merger Sub, LLC, a wholly-owned subsidiary of American Healthcare REIT, Inc. ("AHR"). In the Merger, each share of the Issuer's common stock, par value $0.01 per share, was converted into the right to receive 0.9266 shares of AHR Class I common stock, par value $0.01 per share ("AHR Class I Common Stock"). There is no established market for shares of AHR Class I Common Stock. On March 18, 2021, the board of directors of AHR approved an estimated value per share of AHR Class I Common Stock of $9.22. |
| F2 | The reported shares of common stock were held directly by Streiff Family Trust, UA DTD 3/26/2013, and indirectly by Mathieu Streiff, Trustee. |
| F3 | The reported shares of common stock are owned by Griffin-American Healthcare REIT III Advisor, LLC ("GAHRIII Advisor"), which is 75% owned and managed by wholly owned subsidiaries of AmericanHealthcare Investors, LLC ("American Healthcare Investors"). Mr. Streiff serves as a managing director of American Healthcare Investors, and as such, may be deemed to be the beneficial owner of suchcommon stock. Mr. Streiff disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |